Cargando…
The Potential Role of Passive Antibody-Based Therapies as Treatments for Monkeypox
Monkeypox, a zoonosis caused by the orthopox monkeypox virus (MPXV) that is endemic to Central and West Africa, was previously linked to sporadic outbreaks and rare, travel-associated cases. An outbreak of monkeypox in 2022 has spurred a public health emergency of international concern, and this out...
Autores principales: | Bloch, Evan M., Sullivan, David J., Shoham, Shmuel, Tobian, Aaron A. R., Casadevall, Arturo, Gebo, Kelly A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9765457/ https://www.ncbi.nlm.nih.gov/pubmed/36314809 http://dx.doi.org/10.1128/mbio.02862-22 |
Ejemplares similares
-
The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19
por: Casadevall, Arturo, et al.
Publicado: (2021) -
The Ebola Epidemic Crystallizes the Potential of Passive Antibody Therapy for Infectious Diseases
por: Casadevall, Arturo, et al.
Publicado: (2015) -
Absence of pathogenic viruses in COVID‐19 convalescent plasma
por: Kandathil, Abraham J., et al.
Publicado: (2022) -
Monkeypox: An emerging zoonotic pathogen
por: Beig, Masoumeh, et al.
Publicado: (2022) -
Inequity in the global distribution of monkeypox vaccines
por: Tovani-Palone, Marcos Roberto, et al.
Publicado: (2023)